The expression of endothelin-1 and endothelin-converting enzyme-1 (ECE- 1) are independently regulated in bovine aortic endothelial cells

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 4, 1999, Pages 671-677

  Corder, Roger ^a   Barker, Stewart ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Adenosine; Cytokines; Metallopeptidase; Prohormone processing; Vascular endothelium; Vasoconstriction

Indexed keywords

2 CHLOROADENOSINE; ADENOSINE; CYTOKINE; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; METALLOPROTEINASE; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATTLE; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0032961643     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199904000-00023     Document Type: Article

References (44)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Ikegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem Biophys Res Commun 1990;171:669-75.
3. Sawamura T, Kasuya Y, Matsushita Y, et al. Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells. Biochem Biophys Res Commun 1991;174:779-84.
4. Corder R, Khan N, Harrison VJ. A simple method for isolating human endothelin converting enzyme free from contamination by neutral endopeptidase 24.11. Biochem Biophys Res Commun 1995;207:355-62.
5. Shimada K, Takahashi M, Tanzawa K. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 1994;269:18275-8.
6. Xu D, Emoto N, Giaid A, et al. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994;78:473-85.
7. Ikura T, Sawamura T, Shiraki T, et al. cDNA cloning and expression of bovine endothelin converting enzyme. Biochem Biophys Res Commun 1994;203:1417-22.
8. Schmidt M, Kroger B, Jacob E, et al. Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett 1994;356:238-43.
9. Shimada K, Matsushita Y, Wakabayashi K, et al. Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem Biophys Res Commun 1995;207:807-12.
10. Yorimitsu K, Moroi K, Inagaki N, et al. Cloning and sequencing of a human endothelin converting enzyme in renal adenocarcinoma (ACHN) cells producing endothelin-2. Biochem Biophys Res Commun 1995;208:721-7.
11. Shimada K, Takahashi M, Ikeda M, Tanzawa K. Identification and characterization of two isoforms of endothelin-converting enzyme-1. FEBS Lett 1995;371:140-4.
12. Valdenaire O, Rohrbacher E, Mattei MG. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem 1995;270:29794-98.
13. Schweizer A, Valdenaire O, Nelbock P, et al. Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem J 1997;328:871-7.
14. Bloomquist BT, Eipper BA, Mains RE. Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA. Mol Endocrinol 1991;5:2014-24.
15. Schupin GT, Rhodes CJ. Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin-producing βTC3 cells. Biochem J 1996;313:259-68.
16. Bloomquist BT, Darlington DN, Mains RE, Eipper BA. RESP18, a novel endocrine secretory protein transcript, and four other transcripts are regulated in parallel with proopiomelanocortin in melanotropes. J Biol Chem 1994;269:9113-22.
17. Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR. Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci USA 1995;92:6344-48.
18. Macarthur H, Warner TD, Wood EG, Corder R, Vane JR. Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 1994;200:395-400.
19. Brown CD, Barnes K, Turner AJ. Anti-peptide antibodies specific to rat endothelin-converting enzyme-1 isoforms reveal isoform localisation and expression. FEBS Lett 1998;424:183-7.
20. Elshourbagy NA, Kmetz P, Sathe GM. Nucleotide sequence of endothelin cDNA from bovine endothelial cells. Nucleic Acids Res 1990;18:4273.
21. Bloch KD, Friedrich SP, Lee M-N, Eddy RL, Shows TB, Quertermous T. Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem 1989;264:10851-7.
22. Ercolani L, Florence B, Denaro M, Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988;263:15335-41.
23. Marino MW, Dunbar JD, Wu L-W, et al. Inhibition of tumor necrosis factor signal transduction in endothelial cells by dimethylaminopurine. J Biol Chem 1996;271:28624-9.
24. Marsden PA, Brenner BM. Transcriptional regulation of endothelin-1 gene by TNF-α. Am J Physiol 1992;262:C854-61.
25. Kurihara H, Yoshizumi M, Sugiyama T, et al. Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989;159:1435-40.
26. 2+. Biochem Pharmacol 1995;49:1785-91.
27. Velasco CE, Jackson EK, Morrow JA, Vitola JV, Inagami T, Forman MB. Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischaemia and reperfusion. Cardiovasc Res 1993;27:121-8.
28. Rubanyi G, Vanhoutte PM. Endothelium-removal decreases relaxations of canine coronary arteries caused by β-adrenergic agonists and adenosine. J Cardiovasc Pharmacol 1984;7:139-44.
29. Newman WH, Becker BF, Heier M, Nees S, Gerlach E. Endothelium-mediated coronary dilatation by adenosine does not depend on endothelial adenylate cyclase activation: studies in isolated guinea pig hearts. Pflugers Arch Eur J Physiol 1988;413:1-7.
30. Kobayashi T, Miyauchi T, Sakai S, Yamaguchi I, Goto K, Sugishita Y. Endothelin-converting enzyme and angiotensin-converting enzyme in failing hearts of rats with myocardial infarction. J Cardiovasc Pharmacol 1998;31(suppl 1):S417-20.
31. B-receptor expression in fetal pulmonary hypertension. Am J Physiol 1998;18:L535-41.
32. Wang X, Douglas SA, Louden C, Vickery-Clark LM, Feuerstein GZ, Ohlstein EH. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res 1996;78:322-8.
33. Barnes K, Brown C, Turner AJ. Endothelin-converting enzyme: ultrastructural localization and its recycling from the cell surface. Hypertension 1998;31:3-9.
34. Russell FD, Skepper JN, Davenport AP. Endothelin peptide and converting enzymes in human endothelium. J Cardiovasc Pharmacol 1998;31(suppl 1):S19-21.
35. Davenport AP, Kuc RE, Mockridge JW. Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells. J Cardiovasc Pharmacol 1998;31(suppl 1):S1-3.
36. Grantham JA, Schirger JA, Williamson EE, et al. Enhanced endothelin-converting enzyme immunoreactivity in early atherosclerosis. J Cardiovasc Pharmacol 1998;31(suppl 1):S22-6.
37. Minamino T, Kurihara H, Takahashi M, et al. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 1997;95:221-30.
38. Yanagisawa H, Yanagisawa M, Kapur RP, et al. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 1998;125:825-36.
39. Turner AJ, Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 1997;11:355-64.
40. Haynes WG, Ferro CE, Webb DJ. Physiologic role of endothelin in maintenance of vascular tone in humans. J Cardiovasc Pharmacol 1995;26(suppl 3):S183-5.
41. Smith RM, Brown TJ, Roach AG, Williams KI, Woodward B. Evidence for endothelin involvement in the pulmonary vasoconstrictor response to systemic hypoxia in the isolated rat lung. J Pharmacol Exp Ther 1997;283:419-25.
42. Kwan AL, Bavbek M, Jeng AY, et al. Prevention and reversal of cerebral vasospasm by an endothelin-converting, enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage. J Neurosurg 1997;87:281-6.
43. De Lombaert S, Ghai RD, Jeng AY, Trapani AJ, Webb RL. Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem Biophys Res Commun 1994;204:407-12.
44. Hoang MV, Turner AJ. Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin. Biochem J 1997;328:23-6.